Overexpression of EZH2 has been documented in numerous cancers and shown to be associated with aggressiveness, metastasis, and overall poor outcomes (Bachmann et al., 2006; Simon & Lange, 2008; Takawa et al., 2011). This evidence concerns the gene EZH2 and cancer.